Tata Chemicals Limited has announced its financial results for the quarter and half year ended September 30, 2025, reporting a mixed performance with resilient domestic growth offset by softness in international markets.
Consolidated Performance – Q2 FY26
For the quarter ended September 30, 2025, consolidated revenue from operations stood at ₹3,877 crore, marking a 3% decline compared to ₹3,992 crore in Q2 FY25. The dip was primarily driven by lower realizations and volume pressure across global markets.
EBITDA for the quarter came in at ₹537 crore, down from ₹618 crore in the same period last year, reflecting the impact of subdued demand conditions.
Profit After Tax (before exceptional items and NCI) stood at ₹219 crore, compared to ₹267 crore in Q2 FY25.
As of September 30, 2025, net debt stood at ₹5,583 crore, excluding lease liabilities of ₹776 crore.
Standalone Performance – Q2 FY26
On a standalone basis, Tata Chemicals reported strong domestic growth, with revenue rising 19% year-on-year to ₹1,204 crore, driven by higher sales volumes and improved pricing in key product categories.
EBITDA increased 67% YoY to ₹240 crore, supported by effective cost control measures and better capacity utilization.
Profit After Tax (from continuing operations) surged 80% to ₹178 crore, reflecting operational efficiency gains and improved domestic demand.
Half-Yearly Performance – H1 FY26
For the first half of FY26, consolidated revenue stood at ₹7,596 crore, down 2% YoY due to pricing pressures and muted global demand.
EBITDA was ₹1,186 crore, nearly flat compared to ₹1,192 crore in H1 FY25.
Profit After Tax (before exceptional items and NCI), however, increased to ₹535 crore, up from ₹442 crore in the same period last year, aided by improved performance in the Indian operations.
On a standalone basis, revenue rose 15% YoY to ₹2,373 crore, while EBITDA climbed 35% to ₹510 crore.
PAT grew 37% to ₹485 crore, underscoring the company’s focus on cost discipline and operational excellence.
Disclaimer:
This article is intended solely for educational and informational purposes. The securities or companies mentioned are provided as examples and should not be considered as recommendations. Nothing contained herein constitutes personal financial advice or investment recommendations. Readers are advised to conduct their own research and consult a qualified financial advisor before making any investment decisions.
Investments in securities markets are subject to market risks. Please read all related documents carefully before investing.